logo-loader
AIM:GDR

genedrive PLC

Receive alerts
Market:
AIM
Price
3.41 GBX
Day Change
1.11%
Market Cap:
£4.58 m
52 weeks high
48.86
52 weeks low
3.15

In brief

genedrive PLC is a molecular diagnostics company developing and commercialising a low cost, rapid, versatile, simple to use and robust point of need molecular diagnostics platform for the diagnosis of infectious diseases and for use in patient stratification (genotyping), pathogen detection and other indications.

The company has assays on market for the detection of HCV, certain military biological targets, and has tests in development for tuberculosis (mTB).

genedrive has also released a high throughput SARS-CoV-2 assay.